company? Let’s change
that.
Don't see your company?
Create a company profileVivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system.
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
Nano3D Biosciences develops products for in vitro cell culturing applications.
Memgen is developing viral immunotherapies to harness the power of the immune system to cure cancer and protect people from COVID-19
Award-winning clinical research organization (CRO) that delivers high-quality clinical trials through strong relationships with specialization in oncology, neurology and rare diseases.
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.
1molar inc. is a biomedical technology company.
Animal Life Sciences focuses on the development and commercialization of treatments for cats and dogs based on human cancer technologies.
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Pharm-Olam is a global CRO that is dedicated to helping Sponsors create a healthier world through the development of life-changing treatments.
We are located near the Texas Medical Center in Houston, Texas. Under the leadership of Alice S. Weissfeld, Ph.D., D (ABMM), and Paula H. Vance, SM(NRM), SM(ASCP), CLS(M), msi has remained in the forefront of microbiology testing since 1984 and maintains a reputation for scientifically reliable testing. Originally founded as a clinical microbiology reference laboratory, msi subsequently expanded its services to include environmental microbiology and pharmaceutical and diagnostic trials. MSI has built a strong reputation as a central microbiology lab. Our heritage of scientific and therapeutic excellence translates to the highest standards for our sponsors. Dr. Weissfeld reviews all testing methods and schema to ensure the most efficient and effective study design. We routinely add new tests and evaluate industry trends in order to build our capabilities to support client needs. We offer scientific expertise related to: Protocol consultation Veterinarian Clinical Trials Medical Device Pharmaceutical Please contact us today to discuss your Microbiology needs for any type of clinical trial or USP Compliance.
QuVa Pharma is a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. QuVa was purpose-built to change the 503B industry for the better and is leading the way in making it more safe, efficient, and reliable. With unmatched expertise in cGMPs and sterile pharmaceutical manufacturing, we achieve higher than required quality and safety standards and maintain a leading FDA compliance record, so hospitals can more confidently and reliably focus on patient care. While our leading cGMP processes, sterile-to-sterile portfolio, and expansive capacity of 300,000 sq ft across four facilities are the foundation of success, it is our transparency, customer-focused service, and contracted supply arrangements that enable us to help hospitals and health systems better meet their patient care and operational needs. As FDA compliance becomes more stringent, QuVa's ability to reliably supply the highest-quality products is more valuable than ever and allows hospitals to spend more time on patient care and less time worried about beyond use dates, waste, workload inefficiencies, and compliance. That is why QuVa is proud to be recognized as the partner of choice for many of the nation’s leading health systems. So, whether you are calling for a response or being called on for a solution, know that QuVa is accountable, and in us, you always have an answer.
PCCA is a complete resource for compounding pharmacies. Our members are nearly 4,000 community pharmacists in the United States, Canada, Australia and other countries around the world. We were incorporated in 1981 by a network of pharmacists who recognized the need to help patients requiring customized medications.
At Lonza, we enable A Healthier World by supporting our healthcare customers on the path to commercialization. Our community of 16,000 talented employees work across a global network of more than 30 sites to deliver for our customers across the pharma, biotech and nutrition markets.
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning more than seven decades, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 20,000 associates are enhancing the quality of life through innovative products, partnerships with eye care professionals and programs that advance access to quality eye care.
CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.
Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics.
Tech Pharmacy Services, Inc., doing business as Advanced Pharmacy, designs, develops, implements, and services technology-based solutions.
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.
Work Your Passion. Live Your Purpose.